Minerva Neurosciences (NERV) Tops Q3 EPS by 9c

Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($1.29), $0.09 better than the analyst estimate of ($1.38).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Vireo Growth completes $20M Pennsylvania dispensary license deal
• Spirit Blockchain Capital reports AGM results and board changes